Antiplatelet agents and arterial thrombosis

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


It seems justified and reasonable to prescribe low-dose aspirin for all geriatric patients, and for patients with peripheral arterial disease, clopidogrel for primary prevention. There is, at present, no place for the addition of dipyridamole or oral GPIIb-IIIa antagonists. GPIIb-IIIa antagonists may be indicated in acute events, requiring intervention. Whether patients should be screened for aspirin tolerance or resistance is not clear, but it may be prudent to place patients who fail therapy on a second antiplatelet agent, such as clopidogrel. There is no evidence to suggest that the increase in bleeding that may occur in the elderly should suggest that therapy be withheld and, indeed, there is some evidence that the elderly may derive a relatively increased benefit from the use of these antiplatelet agents.

Original languageEnglish (US)
Pages (from-to)57-74
Number of pages18
JournalClinics in Geriatric Medicine
Issue number1
StatePublished - Feb 2006

ASJC Scopus subject areas

  • Geriatrics and Gerontology


Dive into the research topics of 'Antiplatelet agents and arterial thrombosis'. Together they form a unique fingerprint.

Cite this